ANDREA VAN BEEK: Open Payments
NPI 1760927867 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 22 payments from 9 companies in 2025. Trend: 2023 $1,276 · 2024 $286 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 3 | $203 |
| Merck Sharp & Dohme LLC | 7 | $148 |
| Alnylam Pharmaceuticals Inc. | 3 | $69 |
| Abbott Laboratories | 2 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: DAXXIFY, VERQUVO, AMVUTTRA, MITRACLIP, ELIQUIS, Kerendia, FUROSCIX, CAPVAXIVE.
Industry payments across CA — which companies pay providers there.
